a.Explain the distinctions between ethics and morals.
b.In 1997, the Food and Drug Administration loosened its controls on pharmaceutical companies, and as a result, the amount of prescription drug advertising has skyrocketed. What is a disadvantage of this regulatory change?
c.Explain the “Reasonableness” element of the current FTC policy on deception.
d.Explain the “Injurious” element of the current FTC policy on deception. (24 points)(A 1½-page response is required.)